<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00520026</url>
  </required_header>
  <id_info>
    <org_study_id>FKZ 01 GI9920 / 01 GI0220</org_study_id>
    <nct_id>NCT00520026</nct_id>
  </id_info>
  <brief_title>Suicide Prevention by Lithium - the Lithium Intervention Study</brief_title>
  <acronym>SUPLI</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>University of Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>German Federal Ministry of Education and Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Technische Universität Dresden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bonn</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Erlangen-Nürnberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Schleswig-Holstein</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the proposed suicide preventive effects of lithium in
      a randomized controlled trial within a group of individuals with depressive disorders. The
      hypothesis being tested is that lithium treatment will significantly reduce the risk for
      another suicide attempt.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Several studies have shown that there is a significantly increased risk of suicide related
      mortality in patients with a positive history of suicide attempts. This study is the first
      prospective, randomized, double-blind, placebo controlled multi-center trial focussing on the
      proposed suicide preventive effects of lithium in patients with suicidal behavior but not
      suffering from bipolar disorder or recurrent major depressive disorder. Patients with a
      recent history of a suicide attempt are treated with lithium or placebo during a 12
      month-period. The hypothesis is that lithium treatment will lead to a 50 % reduction of
      suicidal behavior.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    number of enrolled individuals after 5 years still off the estimated sample size
  </why_stopped>
  <start_date>January 2001</start_date>
  <completion_date type="Actual">June 2006</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>occurrence of attempted and completed suicides</measure>
    <time_frame>follow-up period of 1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Specific aspects of the suicide attempt/completed suicide</measure>
    <time_frame>follow-up period of 1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">167</enrollment>
  <condition>Suicide</condition>
  <condition>Depressive Disorders</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lithium treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>lithium</intervention_name>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  suicide attempt within 3 months prior to the first drug administration

          -  occurrence of suicide attempt within the context of an affective spectrum disorder

          -  minimum age of 18 years

          -  ability to complete screening and baseline assessment

          -  ability to understand and provide informed consent

        Exclusion Criteria:

          -  diagnosis of schizophrenia, borderline personality disorder, substance related
             disorders

          -  indication for long-term lithium treatment

          -  thyroid disease

          -  pregnancy and lactation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fritz Hohagen, Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Department of Psychiatry and Psychotherapy, Universitätsklinikum Schleswig-Holstein, Campus Luebeck</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bruno Müller-Oerlinghausen, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Former Research Group Clinical Psychopharmacology, Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Werner Felber, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Psychiatry and Psychotherapy, Medizinische Fakultät der Technischen Universität Dresden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bernd Ahrens, PD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Psychiatry and Psychotherapy, Universitätsklinikum Schleswig-Holstein, Campus Luebeck</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Erik Lauterbach, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Psychiatry and Psychotherapy, Universitätsklinikum Schleswig-Holstein, Campus Luebeck</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Bronisch, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Max-Planck-Institute of Psychiatry Munich</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Psychiatry and Psychotherapy, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>14050</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Psychiatry and Psychotherapy, Rheinische Friedrich-Willhelms-Universität</name>
      <address>
        <city>Bonn</city>
        <zip>53105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Psychiatry and Psychotherapy, Medizinische Fakultät der Technischen Universität Dresden</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Psychiatry and Psychotherapy, Universitätsklinikum Schleswig-Holstein, Campus Luebeck</name>
      <address>
        <city>Luebeck</city>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Psychiatry and Psychotherapy, Klinikum Nuremberg Nord</name>
      <address>
        <city>Nuremberg</city>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Lauterbach E, Ahrens B, Felber W, Oerlinghausen BM, Kilb B, Bischof G, Heuser I, Werner P, Hawellek B, Maier W, Lewitzka U, Pogarell O, Hegerl U, Bronisch T, Richter K, Niklewski G, Broocks A, Hohagen F. Suicide prevention by lithium SUPLI--challenges of a multi-center prospective study. Arch Suicide Res. 2005;9(1):27-34.</citation>
    <PMID>16040577</PMID>
  </reference>
  <reference>
    <citation>Müller-Oerlinghausen B, Felber W, Berghöfer A, Lauterbach E, Ahrens B. The impact of lithium long-term medication on suicidal behavior and mortality of bipolar patients. Arch Suicide Res. 2005;9(3):307-19. Review.</citation>
    <PMID>16020173</PMID>
  </reference>
  <reference>
    <citation>Müller-Oerlinghausen B, Berghöfer A, Ahrens B. The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry. Can J Psychiatry. 2003 Aug;48(7):433-9. Review.</citation>
    <PMID>12971012</PMID>
  </reference>
  <reference>
    <citation>Ahrens B, Müller-Oerlinghausen B. Does lithium exert an independent antisuicidal effect? Pharmacopsychiatry. 2001 Jul;34(4):132-6.</citation>
    <PMID>11518473</PMID>
  </reference>
  <verification_date>August 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 22, 2007</study_first_submitted>
  <study_first_submitted_qc>August 22, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 23, 2007</study_first_posted>
  <last_update_submitted>August 22, 2007</last_update_submitted>
  <last_update_submitted_qc>August 22, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 23, 2007</last_update_posted>
  <keyword>suicide</keyword>
  <keyword>prevention</keyword>
  <keyword>lithium</keyword>
  <keyword>suicidality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Suicide</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lithium Carbonate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

